These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14492926)

  • 1. Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Am J Med Sci; 1962 Apr; 243():502-10. PubMed ID: 14492926
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Antibiot Chemother (Northfield); 1962 Mar; 12():147-51. PubMed ID: 14492925
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin.
    QUINN EL; COLVILLE JM; COX F
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():103-8. PubMed ID: 14435562
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic dysfunction associated with triacetyloleandomycin demonstrated by "challenge".
    ROBINSON MM
    Am J Med Sci; 1962 Aug; 244():221-4. PubMed ID: 14492927
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology and toxicology of propionyl erythromycin ester lauryl sulfate.
    ANDERSON RC; LEE CC; WORTH HM; HARRIS PN
    J Am Pharm Assoc Am Pharm Assoc; 1959 Nov; 48():623-8. PubMed ID: 13848813
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic jaundice due to propionyl erythromycin ester lauryl sulphate ("Ilosone").
    REED C; RITCHIE F
    Med J Aust; 1962 May; 49(i)():810-2. PubMed ID: 14037477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the blood levels obtained with 2 new esters of erythromycin: propionyl erythromycin and propionyl erythromycin lauryl sulfate].
    VIALLIER J; OLLAGNIER C; RONDELET J; AUGAGNEUP J
    Therapie; 1961; 16():878-95. PubMed ID: 13925737
    [No Abstract]   [Full Text] [Related]  

  • 8. Further pharmacological studies on propionyl erythromycin ester lauryl sulfate.
    LEE CC; ANDERSON RC; STEPHENS VC
    Antibiot Chemother (Northfield); 1961 Feb; 11():110-7. PubMed ID: 13760219
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin, oleandomycin and triacetyloleandomycin.
    Ross S
    Pediatr Clin North Am; 1968 Feb; 15(1):119-29. PubMed ID: 4867776
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatosensitization caused by propionyl erythromycin lauryl sulfate.
    GUEVIN R; TEN PAS A
    Henry Ford Hosp Med Bull; 1963 Mar; 11():77-81. PubMed ID: 13951167
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin.
    GILBERT FI
    JAMA; 1962 Dec; 182():1048-50. PubMed ID: 13947810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of propionyl erythromycin lauryl sulfate (S6003)].
    AZUMA I; ABE K; SEO F; KAWAGUCHI S
    Nihon Ganka Kiyo; 1961 Jul; 12():658-64. PubMed ID: 13863582
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of propionyl erythromycin lauryl sulfate].
    TACHIBANA K; ODA S; UEO H
    Hifuka Kiyo; 1961 Sep; 56():259-65. PubMed ID: 13918855
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic hepatitis caused by propionyl erythromycin ester of lauryl sulfate.
    JOHNSON DF; HALL WH
    N Engl J Med; 1961 Dec; 265():1200-2. PubMed ID: 14452017
    [No Abstract]   [Full Text] [Related]  

  • 15. Propionyl erythromycin lauryl sulfate in the treatment of pediatric infections.
    WEIHL C
    J Obstet Gynaecol Br Emp; 1961; 1():28-34. PubMed ID: 13783817
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with the antibiotic triacetyloleandomycin and the combination preparation tetracycline-oleandomycin in childhood].
    DIETEL V; MEISSNER F
    Dtsch Gesundheitsw; 1961 Dec; 16():2470-4. PubMed ID: 13886293
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new anti-staphylococcal agent of value: triacetyloleandomycin. Results of the treatment of various staphylococcias by triacetyloleandomycin in hospital milieu].
    KOSKAS R; ZIRAH P
    Tunis Med; 1961; 39():615-26. PubMed ID: 14458647
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalized eruption from triacetyloleandomycin.
    WELSH AL; EDE M
    Antibiotic Med Clin Ther (New York); 1960 Mar; 7():179-81. PubMed ID: 13843917
    [No Abstract]   [Full Text] [Related]  

  • 19. [Triacetyloleandomycin (P.A. 777)].
    WAREMBOURG H; DESMET G; LEKIEFFRE J
    Lille Med; 1961 Mar; 6():238-43. PubMed ID: 13783140
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of triacetyloleandomycin: in vitro and in vivo studies.
    WERTHAMER S; PECORA CL
    Antibiotic Med Clin Ther (New York); 1960 Sep; 7():560-5. PubMed ID: 13844064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.